Literature DB >> 22506441

Euprolactinemic gynecomastia and galactorrhea with risperidone-fluvoxamine combination.

P J Pratheesh1, Samir Kumar Praharaj, Ashish Srivastava.   

Abstract

Risperidone is associated with hyperprolactinemia and its consequent symptoms such as gynecomastia, galactorrhea and sexual dysfunction in adults, and less so in adolescents. Rarely, serotonin reuptake inhibitors are also associated with such adverse effects. We report a case of gynecomastia and galactorrhea in an adolescent male while on a combination of risperidone and fluvoxamine, although the serum prolactin was within normal range.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22506441      PMCID: PMC5044559     

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  12 in total

1.  Risperidone-induced symptomatic hyperprolactinaemia in adolescents.

Authors:  Laurent Holzer; Chin B Eap
Journal:  J Clin Psychopharmacol       Date:  2006-04       Impact factor: 3.153

2.  Prolactin levels and adverse events in patients treated with risperidone.

Authors:  D L Kleinberg; J M Davis; R de Coster; B Van Baelen; M Brecher
Journal:  J Clin Psychopharmacol       Date:  1999-02       Impact factor: 3.153

3.  Breast tenderness and enlargement induced by sertraline.

Authors:  M J Hall
Journal:  Am J Psychiatry       Date:  1994-09       Impact factor: 18.112

4.  Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.

Authors:  Chih-Ken Chen; Yu-Shu Huang; Shao-Chun Ree; Cheng-Cheng Hsiao
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-08-20       Impact factor: 5.067

5.  Reversible galactorrhea and prolactin elevation related to fluoxetine use.

Authors:  M C Peterson
Journal:  Mayo Clin Proc       Date:  2001-02       Impact factor: 7.616

6.  The effect of fluvoxamine on serum prolactin and serum sodium concentrations: relation to platelet 5-HT2A receptor status.

Authors:  O Spigset; T Mjorndal
Journal:  J Clin Psychopharmacol       Date:  1997-08       Impact factor: 3.153

7.  Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophrenia.

Authors:  Concetta D'Arrigo; Gaetana Migliardi; Vincenza Santoro; Letterio Morgante; Maria Rosaria Muscatello; Maria Ancione; Edoardo Spina
Journal:  Pharmacol Res       Date:  2005-10-11       Impact factor: 7.658

8.  Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.

Authors:  Stefano Erzegovesi; Emanuela Guglielmo; Francesca Siliprandi; Laura Bellodi
Journal:  Eur Neuropsychopharmacol       Date:  2005-01       Impact factor: 4.600

9.  A case with euprolactinemic galactorrhea induced by escitalopram.

Authors:  Murat Gulsun; Ayhan Algul; Umit Basar Semiz; Mehmet Alpay Ates; Ali Doruk; Servet Ebrinc; Cengiz Basoglu; Mesut Cetin
Journal:  Int J Psychiatry Med       Date:  2007       Impact factor: 1.210

10.  A case of galactorrhea associated with excitalopram.

Authors:  Se-Hoon Shim; Yeon-Jeong Lee; Eun-Chan Lee
Journal:  Psychiatry Investig       Date:  2009-07-15       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.